The Latest Breaking News from Viatris

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.27%. US stock indexes this morning are mixed, with the Dow Jones Industrials posing...

The growing demand for innovative drugs, the use of advanced technologies, and growing global healthcare needs boost the pharmaceutical industry’s long-term growth prospects. Therefore, fundamentally strong pharma stocks Viatris (VTRS), Wave Life Sciences (WVE), and MEI Pharma (MEIP) might be ideal additions to your portfolio. Read on.

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Just when it looked like technology stocks took over the S&P 500 — another sector is on the rise.

Portfolio manager Chris Davis discusses his large-cap value stock picks with TheStreet.

Viatris stock popped Monday after the company announced it would divest most of its over-the-counter and women's health businesses.

Asian stocks are mixed after Wall Street rallied and Japanese wages rose ahead of a U.S. inflation update that might influence Federal Reserve plans for possible interest rate hikes

Why deal with the S&P 500 when savings accounts pay 5%? That's exactly why many rich people are dumping stocks for cash.

Carnival led S&P 500 stocks Monday as optimism continues for cruise lines. AMD surged above an early buy point. Catalent was a big loser.

The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market